Congress orders study on opioid surveillance—but skips privacy safeguards
H.R. 2404 — Remote Opioid Monitoring Act of 2025 · Filed by Troy Balderson (R-OH) · 1 cosponsor · Introduced Mar 27, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Comptroller General (the federal government's chief auditor) to study remote monitoring systems for people prescribed opioids within 18 months and report findings to Congress. The study will assess whether remote monitoring works, how widely it is used, and recommend ways to expand access through federal health programs.
Why we flagged it
The bill is a straightforward directive for a government study on a specific health intervention. It does not create new law, regulation, or funding — only a fact-finding obligation with recommendations to follow.
What the text implies
- Study recommendations may lead to federal coverage mandates for remote monitoring, potentially expanding surveillance infrastructure in healthcare without explicit legislative debate on privacy protections.
- Identification of 'cohorts who benefit most' could enable targeted monitoring policies that disproportionately affect certain populations (e.g., low-income, racial minorities, or those with prior substance-use histories).
- Remote monitoring technology vendors and health IT companies stand to benefit from expanded federal coverage recommendations, creating financial incentives that may influence study framing or recommendations.
- The bill does not require the study to assess privacy risks, data security, or potential misuse of monitoring data by law enforcement or insurers — a significant gap in scope.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Remote monitoring could improve opioid safety outcomes and reduce overdose deaths if effective, but the bill does not establish safeguards against surveillance overreach, privacy violations, or coercive use of monitoring data. Citizens gain potential health benefit but face unclear privacy and autonomy risks depending on how recommendations are implemented.
Who stands to gain
- remote monitoring technology vendors
- health IT companies
- telehealth platforms
- pharmaceutical benefit managers
Named in the bill
Comptroller General of the United States, House Committee on Energy and Commerce, Senate Committee on Health, Education, Labor, and Pensions, Senate Committee on Finance, Federal health care programs, Social Security Act Section 1128B
Where it stands
1 cosponsor: 1 Democrats.
- Mar 27, 2025 — Introduced · Congress.gov: “Introduced in House”
- Mar 27, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $3,010,000 in lobbying spend. A filing names 77 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Troy Balderson, the sponsor, reported $1,174,882 in PAC receipts in the 2026 cycle.
- America's Health Insurance Plans Inc (ahip) — $3,010,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,544 characters) on Jun 8, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress orders study on opioid surveillance—but skips privacy safeguards” QuorumCivic. https://share.quorumcivic.app/bill/119/hr2404 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.